ONCURNA Trademark

Trademark Overview

On Monday, December 27, 2021, a trademark application was filed for ONCURNA with the United States Patent and Trademark Office. The USPTO has given the ONCURNA trademark a serial number of 97191521. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, May 9, 2024. This trademark is owned by Oncurna LLC. The ONCURNA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation used in cancer therapeutics

General Information

Serial Number97191521
Word MarkONCURNA
Filing DateMonday, December 27, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, May 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparation used in cancer therapeutics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOncurna LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30318
Party NameOncurna LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30318

Trademark Events

Event DateEvent Description
Tuesday, January 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 30, 2021NEW APPLICATION ENTERED
Wednesday, September 28, 2022ASSIGNED TO EXAMINER
Wednesday, September 28, 2022NON-FINAL ACTION WRITTEN
Wednesday, September 28, 2022NON-FINAL ACTION E-MAILED
Wednesday, September 28, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, January 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, January 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 16, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 16, 2023SOU EXTENSION 1 FILED
Thursday, November 16, 2023SOU EXTENSION 1 GRANTED
Saturday, November 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 9, 2024SOU EXTENSION 2 GRANTED
Thursday, May 9, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 9, 2024SOU EXTENSION 2 FILED
Wednesday, September 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 15, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 25, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 25, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

oncurna therapeutics cancer used preparation pharmaceutical